157 related articles for article (PubMed ID: 736430)
21. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
22. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy.
de Leeuw J; van der Beek N; Maierhofer G; Neugebauer WD
Eur J Dermatol; 2003; 13(5):474-7. PubMed ID: 14693493
[TBL] [Abstract][Full Text] [Related]
23. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
[TBL] [Abstract][Full Text] [Related]
24. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
25. [Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)].
Wolff K; Hönigsmann H; Gschnait F; Konrad K
Dtsch Med Wochenschr; 1975 Nov; 100(48):2471-7, 1497. PubMed ID: 1201723
[TBL] [Abstract][Full Text] [Related]
26. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
Saraceno R; Nisticò SP; Capriotti E; Chimenti S
Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
[TBL] [Abstract][Full Text] [Related]
27. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients.
Czarnowicki T; Harari M; Ruzicka T; Ingber A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):959-63. PubMed ID: 21129041
[TBL] [Abstract][Full Text] [Related]
28. Absence of cataract ten years after treatment with 8-methoxypsoralen.
Bäck O; Hollström E; Lidén S; Thorburn W
Acta Derm Venereol; 1980; 60(1):79-80. PubMed ID: 6153844
[TBL] [Abstract][Full Text] [Related]
29. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
30. Calcipotriene and corticosteroid combination therapy for vitiligo.
Travis LB; Silverberg NB
Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
Halder RM; Battle EF; Smith EM
Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
[No Abstract] [Full Text] [Related]
32. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of vitiligo with ammifurin, beroxan and ultraviolet rays].
Karagezian LA; Rostomian RB; Bagdasarova ZhG
Vestn Dermatol Venerol; 1978 Nov; (11):64-6. PubMed ID: 735345
[No Abstract] [Full Text] [Related]
34. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
35. Treatment of vitiligo with oral 5-methoxypsoralen.
Hann SK; Cho MY; Im S; Park YK
J Dermatol; 1991 Jun; 18(6):324-9. PubMed ID: 1939861
[TBL] [Abstract][Full Text] [Related]
36. Photochemotherapy for psoriasis with orally administered methoxsalen.
Wolff KW; Fitzpatrick TB; Parrish JA; Gschnait F; Gilchrest B; Hönigsmann H; Pathak MA; Tannenbaum L
Arch Dermatol; 1976 Jul; 112(7):943-50. PubMed ID: 820269
[TBL] [Abstract][Full Text] [Related]
37. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
38. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
39. [Photochemotherapy with 8-methoxypsoralen and longwave ultraviolet light. V. Experiences with a new treatment unit (author's transl)].
Meffert H; Metz D; Sönnichsen N
Dermatol Monatsschr; 1978 Jul; 164(7):481-92. PubMed ID: 689223
[No Abstract] [Full Text] [Related]
40. [Epidemiological and clinical profile of vitiligo in Tunisia: retrospective study of 503 cases].
Zeglaoui F; Souissi A; Ben Ayed A; Fazaa B; Kamoun MR
Tunis Med; 2007 Dec; 85(12):1016-9. PubMed ID: 19170379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
